Selective nitrergic neurodegeneration in diabetes mellitus–a nitric oxide‐dependent phenomenon

[1]  F. Murad,et al.  Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry. , 1999, American journal of physiology. Renal physiology.

[2]  R. Dahiya,et al.  Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model , 1999, International Journal of Impotence Research.

[3]  M. Fujimiya,et al.  Effects of endothelial impairment by saponin on the responses to vasodilators and nitrergic nerve stimulation in isolated canine corpus cavernosum , 1999, British journal of pharmacology.

[4]  J. Leza,et al.  Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat , 1998, Microscopy research and technique.

[5]  I. Greer,et al.  Increased Nitrotyrosine in the Diabetic Placenta: Evidence for oxidative stress , 1998, Diabetes Care.

[6]  T. Rabelink,et al.  Nitric oxide availability in diabetes mellitus. , 1998, Diabetes/metabolism reviews.

[7]  R. Davies,et al.  A comparison of the effects of capsaicin with inhibitory nerve stimulation in the rat anococcygeus muscle in vitro. , 1998, European journal of pharmacology.

[8]  M. Santacana,et al.  Distribution of nitric oxide synthase in the esophagus of the cat and monkey. , 1998, Journal of the autonomic nervous system.

[9]  R. Lopes-Martins,et al.  Effect of Tityus serrulatus scorpion venom on the rabbit isolated corpus cavernosum and the involvement of NANC nitrergic nerve fibres , 1998, British journal of pharmacology.

[10]  S. Moncada,et al.  Nitrergic control of peripheral sympathetic responses in the human corpus cavernosum: a comparison with other species. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Moncada,et al.  International Union of Pharmacology Nomenclature in Nitric Oxide Research. , 1997, Pharmacological reviews.

[12]  A. Melman,et al.  Diminished neurogenic but not pharmacological erections in the 2- to 3-month experimentally diabetic F-344 rat. , 1997, The American journal of physiology.

[13]  S. Moncada,et al.  Subcellular localization of nitric oxide synthase in the cerebral ventricular system, subfornical organ, area postrema, and blood vessels of the rat brain , 1997, The Journal of comparative neurology.

[14]  G. Christ,et al.  Characterization of nitroglycerine-induced relaxation in human corpus cavernosum smooth muscle: implications to erectile physiology and dysfunction. , 1995, Canadian journal of physiology and pharmacology.

[15]  J. Rajfer,et al.  Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. , 1995, Endocrinology.

[16]  L. Bégin,et al.  Diabetes mellitus increases nitric oxide synthase in penises but not in major pelvic ganglia of rats. , 1995, British journal of urology.

[17]  S. Moncada,et al.  Characterization of nitrergic neurotransmission during short‐and long‐term electrical stimulation of the rabbit anococcygeus muscle , 1995, British journal of pharmacology.

[18]  L. Ruilope,et al.  Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. , 1994, The American journal of physiology.

[19]  J. Polak,et al.  Localization of nitric oxide synthase in the adult rat brain. , 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[20]  H. Fung,et al.  Pharmacokinetics, plasma protein binding and urinary excretion of Nω‐nitro‐L‐arginine in rats , 1994, British journal of pharmacology.

[21]  A. Melman,et al.  Relationship between contraction and relaxation in human and rabbit corpus cavernosum. , 1993, Urology.

[22]  K. Krejcy,et al.  NG-nitro-L-arginine pharmacokinetics in rats after a single intravascular and oral dose: an appearance of secondary concentration time peaks. , 1993, Drug Metabolism And Disposition.

[23]  K. Anderson.  Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. , 1993, Pharmacological reviews.

[24]  J. Finberg,et al.  Inhibition of nerve stimulation‐induced vasodilatation in corpora cavernosa of the pithed rat by blockade of nitric oxide synthase , 1993, British journal of pharmacology.

[25]  L. Ignarro,et al.  Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. , 1993, The American journal of physiology.

[26]  K M Azadzoi,et al.  Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. , 1992, The Journal of urology.

[27]  S. Snyder,et al.  Nitric oxide: a physiologic mediator of penile erection. , 1992, Science.

[28]  L. Ignarro,et al.  Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. , 1992, The Journal of urology.

[29]  K. Andersson,et al.  Characterization of inhibitory neurotransmission in the isolated corpus cavernosum from rabbit and man. , 1992, The Journal of physiology.

[30]  C. Stief,et al.  Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. , 1991, Acta physiologica Scandinavica.

[31]  S. Snyder,et al.  Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  I. Goldstein,et al.  A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. , 1991, The Journal of clinical investigation.

[33]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[34]  J. Baynes.  Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[35]  M. Rand,et al.  EVIDENCE FOR A ROLE OF NITRIC OXIDE IN THE NEUROTRANSMITTER SYSTEM MEDIATING RELAXATION OF THE RAT ANOCOCCYGEUS MUSCLEC , 1989, Clinical and experimental pharmacology & physiology.

[36]  C. Jf,et al.  [Diabetic autonomic neuropathy]. , 1989, Atencion primaria.

[37]  I. Goldstein,et al.  Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. , 1989, The New England journal of medicine.

[38]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[39]  I. Goldstein,et al.  Cholinergic neurotransmission in human corpus cavernosum. I. Responses of isolated tissue. , 1988, The American journal of physiology.

[40]  T F Lue,et al.  Physiology of erection and pharmacological management of impotence. , 1987, The Journal of urology.

[41]  G. Burnstock,et al.  Changes in the VIPergic, cholinergic and adrenergic innervation of human penile tissue in diabetic and non-diabetic impotent males. , 1987, The Journal of urology.

[42]  G S Brindley,et al.  Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis , 1986, British journal of pharmacology.

[43]  A. Melman,et al.  The possible role of the catecholamines of the corpora in penile erection. , 1979, The Journal of urology.

[44]  M. Jadzinsky,et al.  Impotence and Diabetes: Histological Studies of the Autonomic Nervous Fibers of the Corpora Cavernosa in Impotent Diabetic Males , 1974, Diabetes.

[45]  N. Rakieten,et al.  Studies on the diabetogenic action of streptozotocin (NSC-37917). , 1963, Cancer chemotherapy reports.

[46]  M. Salter,et al.  Measurement of NOS activity by conversion of radiolabeled arginine to citrulline using ion-exchange separation. , 1998, Methods in molecular biology.

[47]  H. Kolb,et al.  Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitor. , 1991, Life sciences.

[48]  S. Balcells,et al.  Impotence and diabetes mellitus. , 1977, European urology.

[49]  N. Rakieten.  Studies on the diabetogenic action of streptozotocin , 1963 .